+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Tolerance to or facilitation of pharmacological effects induced by chronic treatment with the beta-adrenergic stimulant clenbuterol



Tolerance to or facilitation of pharmacological effects induced by chronic treatment with the beta-adrenergic stimulant clenbuterol



Journal of Neural Transmission 62(1-2): 65-76



The effect in mice of chronic administration of the beta-adrenergic agonist clenbuterol was studied using four pharmacological tests, two of which are predictive of antidepressant activity in man. The suppressive effect of acute administration of the beta-adrenergic agonist in two tests unrelated to antidepressant activity, locomotor activity and investigation of food, was attenuated after chronic treatment. However, in the two tests which are predictive of antidepressant activity, antagonism of reserpine induced hypothermia and potentiation of yohimbine toxicity, the effect of clenbuterol was greater following chronic treatment.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041817451

Download citation: RISBibTeXText

PMID: 4020382

DOI: 10.1007/bf01260416


Related references

Lesions of the serotonergic system impair the facilitation of but not the tolerance to the effects of chronic clenbuterol administration. Psychopharmacology 91(4): 496-499, 1987

Enzyme immunoassay for clenbuterol a beta 2 adrenergic stimulant. Journal of Immunoassay 3(2): 155-172, 1982

Tolerance to the behavioral effects of the centrally active beta adrenergic agonist clenbuterol. Society for Neuroscience Abstracts 14(1): 305, 1988

Use of a beta 2-adrenergic stimulant (clenbuterol) for eliminating night-time calving. Journal of Veterinary Medical Science 54(1): 19-22, 1992

Use of a .Beta.2-Adrenergic Stimulant(Clenbuterol) for Eliminating Night-Time Calving. The Journal of Veterinary Medical Science 54(1): 19-22, 1992

Selective regulation of beta 2 adrenergic receptors by chronic administration of the lipophilic beta adrenergic receptor agonist clenbuterol an autoradiographic study. Journal of Pharmacology & Experimental Therapeutics 242(2): 707-712, 1987

Selective regulation of beta-2 adrenergic receptors by the chronic administration of the lipophilic beta adrenergic receptor agonist clenbuterol: an autoradiographic study. Journal of Pharmacology and Experimental Therapeutics 242(2): 707-712, 1987

Effect of long term beta-1-adrenergic receptor stimulant treatment on cardiac adrenergic function in chronic heart failure As assessed using MIBG-TL dual SPECT. Japanese Circulation Journal 58(7): 461, 1994

Disappearance of the decrease in biting behavior induced by clenbuterol, a beta-adrenergic agonist, after chronic administration. Pharmacology, Biochemistry, and Behavior 21(2): 313-316, 1984

Behavioral effects of beta adrenergic agonists and antidepressant drugs after down-regulation of beta-2 adrenergic receptors by clenbuterol. Journal of Pharmacology and Experimental Therapeutics 254(1): 147-157, 1990

Pharmacological and clinical aspects of the use in cattle of the beta-2 mimetic adrenergic drug clenbuterol. Clinica Veterinaria 100(10): 671-676, 1977

Prevention of cyclosporine-induced nephrotoxicity by clenbuterol, a beta 2-adrenoreceptor stimulant. Transplantation Proceedings 28(3): 1976-1977, 1996

Contribution to the pharmacological study of a new beta adrenergic stimulant: Salbutamol. Prensa Medica Argentina 58(23): 1163-1170, 1971

Effects of a beta-adrenergic stimulant: Salbutamol, on spontaneous or induced bronchial obstruction in asthma. Marseille Medical 109(11): 713-717, 1972

Potentiating effect of beta-adrenergic stimulant on the response of the cutaneous vascular resistance to alpha-adrenergic stimulant. Experientia 31(5): 552-554, 1975